GI
AMRX icon

GAMMA Investing’s Amneal Pharmaceuticals AMRX Stock Holding History

GAMMA Investing’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32.3K Buy
1,605
+569
+55% +$10.3K ﹤0.01% 2640
2026
Q2 		$17.9K Buy
1,036
+319
+44% +$4.37K ﹤0.01% 2892
2026
Q1 		$8.91K Buy
717
+156
+28% +$2.1K ﹤0.01% 3127
2025
Q4 		$7.07K Buy
561
+62
+12% +$709 ﹤0.01% 3130
2025
Q3 		$5K Sell
499
-3
-0.6% -$27 ﹤0.01% 3182
2025
Q2 		$4.06K Buy
502
+125
+33% +$942 ﹤0.01% 3198
2025
Q1 		$3.16K Buy
377
+325
+625% +$2.71K ﹤0.01% 3254
2024
Q4 		$412 Buy
52
+27
+108% +$227 ﹤0.01% 3606
2024
Q3 		$208 Sell
25
-39
-61% -$305 ﹤0.01% 3492
2024
Q2 		$406 Buy
64
+36
+129% +$229 ﹤0.01% 3244
2024
Q1 		$170 Buy
+28
New +$158 ﹤0.01% 3240

Other funds holding AMRX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
SFGP
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.36B AUM 14.31% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's AMRX Position: Q3 2026 in Review

GAMMA Investing increased its Amneal Pharmaceuticals (AMRX) stake by 55% in Q3 2026, buying an estimated $10.3K and bringing the position to 1,605 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

GAMMA Investing first reported a position in AMRX in Q1 2024 and has held it in 11 quarters since. 14 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • GAMMA Investing held 1,605 shares of Amneal Pharmaceuticals worth $32.3K as of Q3 2026.
  • GAMMA Investing bought 569 Amneal Pharmaceuticals shares in Q3 2026, an estimated $10.3K.
  • Amneal Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2640 holding.
  • GAMMA Investing first reported a position in Amneal Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • 14 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.